Epidemiology of community- and nursing home-acquired pneumonia in older adults

References

• Pneumonia and influenza death rates, United States, 1979–1994. Morbid. Mortal. Wkly Rep. 44, 535–537 (1995).
   PubMedGoogle Scholar
• Canadian Institute for Health Information. Health Report. Canadian Institute for Health Information, Ottawa, Canada (1997).
   Google Scholar
• Jokinen C, Heiskanen L, Juvonen H et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am. J. Epidemiol. 137(9), 977–988 (1993).
   PubMed Web of Science ®Google Scholar
• Muder R. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management and prevention. Am. J. Med. 105, 319–330 (1998).
   PubMed Web of Science ®Google Scholar
• Spillman BC, Lubitz J. The effect of longevity on spending for acute and long-term care. N. Engl. J. Med. 342, 1409–1415 (2000).
   PubMed Web of Science ®Google Scholar
• 2000 annual report of the board of trustees of the Federal Old-Age and Survivors Insurance and Disability Insurance Trust Funds. Social Security Administration, MD, USA (2000).
   Google Scholar
• Jokinen C, Heiskanen L, Juvonen H et al. Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin. Infect. Dis. 32(8), 1141–1154 (2001).
   PubMed Web of Science ®Google Scholar
• Marrie TJ. Community-acquired pneumonia in the elderly. Clin. Infect. Dis. 31, 1066–1078 (2000).
   PubMed Web of Science ®Google Scholar
• Marrie TJ, Fine M, Coley C. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am. J. Med. 101, 508–515 (1996).
   PubMed Web of Science ®Google Scholar
• Ruiz M, Ewig S, Marcos M et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am. J. Resp. Crit. Care Med. 160, 397–405 (1999).
   PubMed Web of Science ®Google Scholar
• Lieberman D, Lieberman D, Schlaeffer F, Porath A. Community-acquired pneumonia in older age: a prospective study of 91 patients admitted from home. Age Ageing 26, 69–75 (1997).
   PubMedGoogle Scholar
• Marrie TJ. Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly. Arch. Intern. Med. 153, 488–494 (1993).
   PubMedGoogle Scholar
• Woodhead M. Pneumonia in the elderly. J. Antimicrob. Chemother. 34(Suppl. 34), 85–92 (1994).
   PubMedGoogle Scholar
• Rello J, Rodriguez R, Jubert P et al. Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Clin. Infect. Dis. 23, 723–728 (1996).
   PubMed Web of Science ®Google Scholar
• El-Solh AA, Sikka P, Ramadan F, Davies J. Etiology of severe pneumonia in the very elderly. Am. J. Respir. Crit. Care Med. 163, 645–651 (2001).
   PubMed Web of Science ®Google Scholar
• Koivula I, Sten M, Makela PH. Risk factors for pneumonia in the elderly. Am. J. Med. 96, 313–320 (1994).
   PubMed Web of Science ®Google Scholar
• Farr BM, Woodhead MA, Macfarlane JT et al. Risk factors for community-acquired pneumonia diagnosed by general practitioners in the community. Respir. Med. 94, 422–427 (2000).
   PubMed Web of Science ®Google Scholar
• Riquelme R, Torres A, El-Ebiary M et al. Community-acquired pneumonia in the elderly: a multivariate analysis of risk and prognostic factors. Am. J. Respir. Crit. Care Med. 154, 1450–1455 (1996).
   PubMed Web of Science ®Google Scholar
• Metlay JP, Schulz R, Li YH et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch. Intern. Med. 157(13), 1453–1459 (1997).
   PubMedGoogle Scholar
• Marrie TJ, Haldane EV, Faulkner RS et al. Community-acquired pneumonia requiring hospitalization: is it different in the elderly? J. Am. Geriatr. Soc. 33, 671–680 (1985).
   PubMed Web of Science ®Google Scholar
• Johnson JC, Jayadevappa R, Baccash PD, Taylor L. Nonspecific presentation of pneumonia in hospitalized older people: age effect or dementia? J. Am. Geriatr. Soc. 48, 1316–1320 (2000).
   PubMedGoogle Scholar
• Roghmann M, Warner J, Mackowiak PA. The relationship between age and fever magnitude. Am. J. Med. Sci. 322, 68–70 (2001).
   PubMed Web of Science ®Google Scholar
• Gleason PP, Kapoor WN, Stone RA et al. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for out-patients with community-acquired pneumonia. J. Am. Med. Assoc. 278, 32–39 (1997).
   PubMed Web of Science ®Google Scholar
• Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin. Infect. Dis. 37, 1405–1433 (2003).
   PubMed Web of Science ®Google Scholar
• Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch. Intern. Med. 159(21), 2562–2572 (1999).
   PubMed Web of Science ®Google Scholar
• Meehan TP, Fine MJ, Krumholz HM et al. Quality of care, process, and outcomes in elderly patients with pneumonia. J. Am. Med. Assoc. 278(23), 2080–2084 (1997).
   PubMed Web of Science ®Google Scholar
• Fine MJ, Auble TE, Yealy DM et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 336, 243–250 (1997).
   PubMed Web of Science ®Google Scholar
• Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG. A critical pathway for treatment of community-acquired pneumonia. J. Am. Med. Assoc. 283(20), 2654–2655 (2000).
   Google Scholar
• Conte HA, Chen Y-T, Mehal W, Scinto JD, Quagliarello VJ. A prognostic rule for elderly patients admitted with community-acquired pneumonia. Am. J. Med. 106, 20–28 (1999).
   PubMed Web of Science ®Google Scholar
• Lim WS, Macfarlane JT. Defining prognostic factors in the elderly with community-acquired pneumonia: a case controlled study of patients aged 75 yrs or over. Eur. Respir. J. 17, 200–205 (2001).
   PubMedGoogle Scholar
• Koivula I, Sten M, Makela PH. Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study. Arch. Intern. Med. 159(14), 1550–1555 (1999).
   PubMedGoogle Scholar
• Metersky ML, Tate JP, Fine MJ, Petrillo MK, Meehan TP. Temporal trends in outcomes of older patients with pneumonia. Arch. Intern. Med. 160, 3385–3391 (2000).
   PubMedGoogle Scholar
• LaCroix AZ, Lipson S, Miles TP, White L. Prospective study of pneumonia hospitalizations and mortality of US older people: the role of chronic conditions, health behaviors, and nutritional status. Pub. Health Rep. 104, 350–360 (1989).
   PubMed Web of Science ®Google Scholar
• Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann. Intern. Med. 123, 518–527 (1995).
   PubMed Web of Science ®Google Scholar
• Hirschmann JV, Lipsky BA. The pneumococcal vaccine after 15 years of use. Arch. Intern. Med. 154, 373–377 (1994).
   PubMedGoogle Scholar
• Fedson DS, Shapiro ED, Laforce FM et al. Pneumococcal vaccine after 15 years of use. Another view. Arch. Intern. Med. 154, 2531–2535 (1994).
   PubMedGoogle Scholar
• Fine M, Smith MA, Carson CA et al. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch. Intern. Med. 154, 2666–2677 (1999).
   Google Scholar
• Hutchison BG, Oxman AD, Shannon HS, Lloyd S, Altmayer CA, Thomas K. Clinical effectiveness of pneumococcal vaccine. Can. Fam. Physician 45, 2381–2393 (1994).
   Google Scholar
• Moore RA, Wiffen PJ, Lipsky BA. Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials. BMC Fam. Pract. 1(1), 1 (2000).
   PubMedGoogle Scholar
• Cornu C. Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials. Vaccine 19(32), 4780–4790 (2001).
   PubMed Web of Science ®Google Scholar
• Gaillat J, Zmirou D, Mallaret MR et al. Essai clinique du vaccin antipneumococcique chez des personnages agées vivant en institution. Rev. Epidem. Santé Publ. 33, 437–444 (1985).
   PubMed Web of Science ®Google Scholar
• Klatersky J, Mommen P, Canteraine F, Safary A. Placebo-controlled pneumococcal immunization in patients with bronchogenic carcinoma. Eur. J. Cancer Clin. Oncol. 22, 807–813 (1986).
   PubMedGoogle Scholar
• Simberkoff MS, Cross AP, Al-Ibrahim M et al. Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. N. Engl. J. Med. 315, 1318–1327 (1986).
   PubMed Web of Science ®Google Scholar
• Davis AL, Aranda CP, Schiffman G, Christianson LC. Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. Chest 92, 202–212 (1987).
   Google Scholar
• Leech JA, Gervais A, Ruben FL. Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease. Can. Med. Assoc. J. 136, 361–365 (1987).
   Google Scholar
• Koivula I, Stén M, Leinonen M, Mäkelä PH. Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based study. Am. J. Med. 103, 281–290 (1997).
   PubMed Web of Science ®Google Scholar
• Örtqvist A, Hedlund J, Burman LA et al. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet 351, 399–403 (1998).
   PubMed Web of Science ®Google Scholar
• Shapiro ED, Berg AT, Austrian R et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N. Engl. J. Med. 325(21), 1453–1460 (1991).
   PubMed Web of Science ®Google Scholar
• Sims RV, Steinmann WC, McConville JH, King LR, Zwick WC, Schwartz JS. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann. Intern. Med. 108(5), 653–657 (1998).
   Google Scholar
• Farr BM, Johnston BL, Cobb DK et al. Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study. Arch. Intern. Med. 155(21), 2336–4230 (1995).
   PubMed Web of Science ®Google Scholar
• Broome CV, Facklam RR, Fraser DW. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N. Engl. J. Med. 303(10), 549–552 (1980).
   PubMed Web of Science ®Google Scholar
• Nichol KL, Baken L, Wuorenma J, Nelson A. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch. Intern. Med. 159(20), 2437–2442 (1999).
   PubMed Web of Science ®Google Scholar
• Valenti WM, Trudell RG, Bentley DW. Factors predisposing to oropharyngeal colonization with Gram-negative bacilli in the aged. N. Engl. J. Med. 298, 1108–1111 (1978).
   PubMed Web of Science ®Google Scholar
• Orr PH, Peeling RW, Fast M et al. Serological study of responses to selected pathogens causing respiratory tract infection in the institutionalized elderly. Clin. Infect. Dis. 23, 1240–1245 (1996).
   PubMedGoogle Scholar
• Loeb M, Simor AE, Krueger P et al. Two nursing home outbreaks of respiratory infection with Legionella sainthelensi. J. Am. Geriat. Soc. 47, 547–552 (1999).
   PubMed Web of Science ®Google Scholar
• Troy CJ, Peeling RW, Ellis AG et al. Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes. J. Am. Med. Assoc. 277, 1214–1218 (1997).
   PubMed Web of Science ®Google Scholar
• Loeb M, McGeer A, McArthur M, Walter S, Simor AE. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch. Intern. Med. 159, 2058–2064 (1999).
   PubMed Web of Science ®Google Scholar
• Vergis EN, Brennen C, Wagener M, Muder RR. Pneumonia in long-term care: a prospective case-control study of risk factors and impact on survival. Arch. Intern. Med. 161, 2378–2381 (2001).
   PubMed Web of Science ®Google Scholar
• Baine WB, Yu W, Summe JP. Epidemiologic trends in the hospitalization of elderly medicare patients for pneumonia, 1991–1998. Am. J. Pub. Health 91, 1121–1123 (2001).
   Google Scholar
• Marrie TJ, Blanchard W. A comparison of nursing home-acquired pneumonia patients with patients with community-acquired pneumonia and nursing home patients without pneumonia. J. Am. Geriatr. Soc. 45, 50–55 (1997).
   PubMed Web of Science ®Google Scholar
• Phillips SL, Branaman-Phillips J. The use of intramuscular cefoperazone versus intramuscular ceftriaxone in patients with nursing home-acquired pneumonia. J. Am. Geriatr. Soc. 41, 1071–1074 (1993).
   PubMedGoogle Scholar
• Hirata-Dulas CA, Stein DJ, Guay DR, Gruninger RP, Peterson PK. A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections. J. Am. Geriatr. Soc. 39, 979–985 (1991).
   PubMed Web of Science ®Google Scholar
• Peterson PK, Stein D, Guay DRP et al. Prospective study of lower respiratory tract infections in an extended-care nursing home program: potential role of oral ciprofloxacin. Am. J. Med. 85, 164–171 (1988).
   PubMed Web of Science ®Google Scholar
• Naughton BJ, Mylotte JM. Treatment guideline for nursing home-acquired pneumonia based on community practice. J. Am. Geriatr. Soc. 48, 82–88 (2000).
   PubMed Web of Science ®Google Scholar
• Naughton BJ, Mylotte JM. Antibiotic use, hospital admissions, and mortality before and after implementing guidelines for nursing home-acquired pneumonia. J. Am. Geriatr. Soc. 49, 1020–1024 (2001).
   PubMedGoogle Scholar
• Loeb M, Simor AE, Landry L, McGeer A. Adherence to antibiotic guidelines for pneumonia in chronic-care facilities in Ontario. Clin. Invest. Med. 24, 304–310 (2001).
   PubMedGoogle Scholar
• Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N. Engl. J. Med. 341, 233–239 (1999).
   PubMed Web of Science ®Google Scholar
• Delegau J, Guay D, Straub K, Luxenberg MG. Effectiveness of oral antibiotic treatment in nursing home-acquired pneumonia. J. Am. Geriatr. Soc. 43, 245–251 (1995).
   PubMedGoogle Scholar
• Thompson RS, Hall NK, Szpiech M, Reisenberg LA. Treatments and outcomes of nursing- home acquired pneumonia. J. Am. Board Fam. Pract. 10, 82–87 (1997).
   PubMedGoogle Scholar
• Fried TR, Gillick MR, Lipsitz LA. Whether to transfer? Factors associated with hospitalization and outcome of elderly long-term care patients with pneumonia. J. Gen. Intern. Med. 10, 246–250 (1995).
   PubMed Web of Science ®Google Scholar
• Fried TR, Gillick MR, Lipsitz LA. Short-term functional outcomes of long-term care residents with pneumonia treated with and without hospital transfer. J. Am. Geritat. Soc. 45, 302–306 (1997).
   PubMed Web of Science ®Google Scholar
• Mylotte JM, Naughton B, Saludades S, Maszarovics Z. Validation and application of the pneumonia prognosis index to nursing home residents with pneumonia. J. Am. Geritat. Soc. 46, 1538–1544 (1998).
   PubMed Web of Science ®Google Scholar
• Muder RR, Brennen C, Swenson DL, Wagener M. Pneumonia in a long-term care facility. A prospective study of outcome. Arch. Intern. Med. 156, 2365–2370 (1996).
   PubMed Web of Science ®Google Scholar
• Mehr DR, Zweig SC, Kruse RL et al. Mortality from lower respiratory tract infection in nursing home residents. A pilot prospective community-based study. J. Fam. Pract. 47, 298–304 (1998).
   PubMed Web of Science ®Google Scholar
• Mehr DR, Foxman B, Colombo P. Risk factors for mortality from lower respiratory infections in nursing home patients. J. Fam. Pract. 34, 585–591 (1992).
   PubMedGoogle Scholar
• Naughton BJ, Mylotte JM, Tayara A. Outcome of nursing home-acquired pneumonia: derivation and application of a practical model to predict 30-day mortality. J. Am. Geriatr. Soc. 48, 1292–1299 (2000).
   PubMed Web of Science ®Google Scholar
• Mehr DR, Binder EF, Kruse RL et al. Predicting mortality in nursing home residents with lower respiratory tract infection: the Missouri LRI Study. J. Am. Med. Assoc. 286, 2427–2436 (2001).
   PubMed Web of Science ®Google Scholar
• Potter J, Stott DJ, Roberts MA et al. Influenza vaccination of healthcare workers in long-term care hospitals reduces the mortality of elderly patients. J. Infect. Dis. 175, 1–6 (1997).
   PubMed Web of Science ®Google Scholar
• Carman WF, Elder AG, Wallace LA et al. Effects of influenza vaccination of healthcare workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 355, 93–97 (2000).
   PubMed Web of Science ®Google Scholar